Comparing CML Gr-MDSCs to autologous polymorphonuclear leukocytes (PMNs) we observed a higher Arg1 expression and activity in PMNs, together with an inhibitory effect on T cells in vitro. Here, ARG1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.